Physician profile
Heather B Seith
NPI 1972579191
$3,188.19
in general payments reported to CMS, 2019-2025
18 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.18 · 2020: $80.96 · 2021: $207 · 2022: $467 · 2023: $365 · 2024: $677 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,269 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.36 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,268.36 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Mallinckrodt Hospital Products INC. | $516.55 | 2024-2025 | Acthar |
| Allergan, INC. | $259.41 | 2019-2021 | |
| Alcon Vision LLC | $193.88 | 2022-2025 | Tryptyr, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $145.02 | 2023 | Tecnis Iol |
| E.R. Squibb & Sons, L.L.C. | $121.84 | 2025 | Opdivo |
| Rayner Intraocular Lenses Limited | $120.65 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Apellis Pharmaceuticals, INC. | $117.73 | 2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $102.86 | 2025 | Purified Cortrophin Gel |
| New World Medical,INC. | $96.81 | 2022 | |
| Aerie Pharmaceuticals, INC. | $72.39 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $37.75 | 2024 | Xdemvy |
| Astellas Pharma US INC | $33.01 | 2025 | Izervay |
| Glaukos Corporation | $23.58 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $23.10 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $20.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.59 | 2021 | |
| Dompe US, INC. | $15.66 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Seith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.